ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

“Over-Regulation” Threatens Health Care, Thompson Says.

June 15, 2001

DCE Board Demands Other Agencies Pay For NCI AIDS Support Contract, Okays Two RFA Concepts, One Program Announcement, Contract Recompetitions

May 24, 1985

Meharry, Vanderbilt Win Grant For Research Collaboration.

March 30, 2001

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

NCA Approves New Guidelines For Comprehensive Review

December 8, 1989